DNASE1L3 and hepatocellular carcinoma: Finally, to investigate the potential of DNASE1L3 as a novel biomarker for human HCC, we examined the serum levels of DNASE1L3 in 72 patients with HCC and 54 healthy individuals (cohort II) by ELISA.